Clinical Advisory Council
Cancer care is complex and ever-changing, particularly with recent advances in tumor biology and the development and approval of novel treatments guided by molecular testing. Due to this complexity, a conglomerate of the brightest minds is needed to understand and steer the future of the industry as there is far too much information for any one individual to master. VieCure’s Clinical Advisory Council comprises global leaders from top cancer programs, universities, and institutes who review clinical evidence, evaluate literature, and research Oncology treatments to develop algorithms and codified clinical rules to be actioned within
the VieCure™ A.I. platform.
Why does VieCure need a
Clinical Advisory Council?
Assist in creating and updating evidence-based treatment plans, rules, and algorithms for the VieCure clinical inference engine to facilitate cutting-edge point-of-care decision making
Analyze de-identified clinical data to expose opportunities such as potential new targets for research and treatment
Leverage professional network to improve patient care by providing strategic advice on new directions in cancer care and research across the globe
How will patient's benefit from VieCure's Clinical Advisory Council?
Oncologists have access to personalized patient treatment plans based on the most recent
advances in cancer
Tools within the VieCure platform are used to manage toxicities, monitor treatment compliance, achieve better outcomes and improve quality of life throughout treatment
Facilitate ongoing education by providing clinical providers easy access to the most current information regarding the patient’s disease, treatment, and supportive care
Clinical Advisory Council Members
Jennifer Choi, MD
Chief, Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center
Associate Professor, Dermatology, Feinberg School of Medicine, Northwestern University, Illinois, USA